AMARIN CORP PLC\UK Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions
AMARIN CORP PLC\UK (AMRN) reported Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions of $256.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-27.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions · last filed 2014-02-27
- AMARIN CORP PLC\UK unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2013 was $256.00K, a 433.33% increase from fiscal 2012.
- AMARIN CORP PLC\UK unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2012 was $48.00K.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2013-12-31 | $256.00K 10-K · filed 2014-02-27 |
| 2012-12-31 | $48.00K 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |